Novel small molecule activators of β-catenin-mediated signaling pathway: structure-activity relationships of indirubins

被引：12
|
作者：
Park, Eun-Jung [1 ]
Choi, Soo Jeong [2 ]
Kim, Yong-Chul [2 ]
Lee, Sang Hyung [3 ]
Park, Seoung Woo [4 ]
Lee, Sang Kook [1 ]
机构：
[1] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea
[2] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea
[3] Seoul Natl Univ, Coll Med, Seoul 156707, South Korea
[4] Kangwon Natl Univ, Sch Med, Chunchon 200947, Gangwon, South Korea
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 08期
关键词：
Wnt signaling; Novel activator of Wnt signaling; Indirubin; 5-Nitro-3 '-monoxime; beta-Catenin; WNT; KINASE; DERIVATIVES; INHIBITORS; ADHESION;
D O I：
10.1016/j.bmcl.2009.02.083
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Based on the beta-catenin-drived Wnt activator of bromoindirubin-3'-oxime (BIO), indirubin analogs were evaluated for beta-catenin-mediated gene expression. A novel indirubin analog, indirubin-5-nitro-3'-oxime (INO), was considered a potential activator, and structure-activity studies were conducted with indirubins. These data suggest that INO might be a novel Wnt activator and has a potential of signaling regulator in beta-catenin-mediated signaling pathways. (c) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2282 / 2284
页数：3
相关论文
共 50 条
  • [31] Structure-activity relationships of novel potent MurF inhibitors
    Gu, YG
    Florjancic, AS
    Clark, RF
    Zhang, TY
    Cooper, CS
    Anderson, DD
    Lerner, CG
    McCall, JO
    Cai, YN
    Black-Schaefer, CL
    Stamper, GF
    Hajduk, PJ
    Beutel, BA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) : 267 - 270
  • [32] Synthesis and Structure-Activity Relationships of Novel Neocryptolepine Derivatives
    El-Gokha, Ahmed A.
    Boshta, Nader M.
    Hussein, Mona K. Abo
    El Sayed, Ibrahim El-T.
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 33 (03) : 373 - 377
  • [33] Synthesis and structure-activity relationships in a novel class of herbicides
    Mitchell, G
    Barnes, NJ
    Cox, JM
    Matthews, IR
    Pearson, DPJ
    Smith, SC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U63 - U63
  • [34] The development of novel telomerase inhibitors: Structure-activity relationships
    Cheng, MK
    Modi, C
    Grindon, CR
    Stevens, MFG
    Laughton, CA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S40 - S40
  • [35] Preparation and structure-activity relationships of novel asterriquinone derivatives
    Kaji, A
    Kimura, K
    Teranishi, M
    Kiriyama, N
    Nomura, M
    Miyamoto, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1998, 46 (08) : 1325 - 1329
  • [36] Synthesis and structure-activity relationships of novel warfarin derivatives
    Gebauer, Markus
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (06) : 2414 - 2420
  • [37] Structure-activity relationships of a novel Dynorphin A analogue.
    Charoenchai, L
    Choi, H
    Murray, TF
    Aldrich, JV
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U289 - U290
  • [38] MEDI 203-Discovery and structure-activity relationships of potent and selective PPARalpha activators
    Ye, Xiang-Yang
    Chen, Stephanie Y.
    Zhang, Hao
    Tao, Shiwei
    Li, Jun
    Kennedy, Lawrence J.
    Shi, Yan
    Hernandez, Andres
    Chen, Sean
    Devasthale, Pratik V.
    Wang, Wei
    Locke, Kenneth T.
    O'Malley, Kevin
    Zhang, Litao
    Srivastava, Raiajit
    Miao, Bowman
    Meyers, Daniel S.
    Monshizadegan, Hossain
    Search, Debra
    Grimm, Denise
    Zhang, Rongan
    Harrity, Thomas
    Kunselman, Lori K.
    Caps, Michael
    Muckelbauer, Jodi
    Chang, Chiehying
    Krystek, Stanley, Jr.
    Hosagrahara, Vinayak
    Zhang, Lisa
    Kadiyala, Pathanjali
    Xu, Carrie
    Blanar, Michael A.
    Zahler, Robert
    Mukherjee, Ranjan
    Cheng, Peter T.
    Tino, Joseph A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [39] Novel small molecule inhibitors of Jak2/STAT3 pathway: design, structure-activity relationship, and oral bioavailability
    Priebe, W.
    Fokt, I.
    Szymanski, S.
    Bao, Y.
    Conrad, C.
    Chakraborty, A.
    Abbruzzese, J.
    Guha, S.
    Myers, J.
    Madden, T.
    EJC SUPPLEMENTS, 2006, 4 (12): : 169 - 169
  • [40] LC-363:: Optimization and in vitro characterization of a novel series of small molecule inhibitors of the Wnt/β-catenin signaling pathway
    Strovel, Jeffrey W.
    Lonskaya, Irina
    Natarajan, Pachai
    Lawrence, Tammy
    Glanowski, Stephen
    Weaver, Zoe
    Padia, Janak
    Watthey, Jeffrey W.
    Cholody, Wieslaw M.
    Chellappan, Sheela K.
    Ohler, Norman E.
    Bol, David K.
    Horrigan, Stephen K.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3599S - 3599S
12345